Panax notoginseng saponins promotes stroke recovery by influencing expression of Nogo-A, NgR and p75NGF, in vitro and in vivo

Biological and Pharmaceutical Bulletin

Volumn 37, Issue 4, 2014, Pages 560-568

  Liu, Lixing ^a   Zhu, Lingqun ^a   Zou, Yihuai ^a   Liu, Wei ^a   Zhang, Xiaoqian ^a   Wei, Xiaoqin ^a   Hu, Bo ^a   Chen, Jiaxu ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Cerebral infarction; NgR; Nogo A; p75; Panax notoginseng saponin

Indexed keywords

MESSENGER RNA; NEUROPROTECTIVE AGENT; NEUROTROPHIN RECEPTOR P75; NIMODIPINE; NOGO 66 RECEPTOR; PANAX NOTOGINSENG SAPONIN; PROTEIN NOGO A; SAPONIN; UNCLASSIFIED DRUG; HERBACEOUS AGENT; MYELIN PROTEIN; NERVE GROWTH FACTOR RECEPTOR; NGR PEPTIDE; OLIGOPEPTIDE; PROTEIN NOGO; TNFRSF16 PROTEIN, RAT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG MEGADOSE; GENE EXPRESSION; HUMAN; HUMAN CELL; LOADING DRUG DOSE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVOUS SYSTEM FUNCTION; NEUROBLASTOMA CELL; NONHUMAN; PANAX NOTOGINSENG; PROTEIN EXPRESSION; RAT; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; CONVALESCENCE; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; PHYTOTHERAPY; STROKE;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; GENE EXPRESSION REGULATION; MALE; MYELIN PROTEINS; OLIGOPEPTIDES; PANAX NOTOGINSENG; PHYTOTHERAPY; RATS; RECEPTORS, NERVE GROWTH FACTOR; RECOVERY OF FUNCTION; SAPONINS; STROKE;

EID: 84898733502     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b13-00770     Document Type: Article

References (33)

1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics - 2012 Update: A Report from the American Heart Association. Circulation, 125, 188-197 (2012).
2. Kelly-Hayes M, Beiser A, Kase CS, Scaramucci A, D'Agostino RB, Wolf PA. The influence of gender and age on disability following ischemic stroke: the Framingham study. J. Stroke Cerebrovasc. Dis., 12, 119-126 (2003).
3. Gonzenbach RR, Schwab ME. Disinhibition of neurite growth to repair the injured adult CNS: Focusing on Nogo. Cell. Mol. Life Sci., 65, 161-176 (2008).
4. Quarles RH. Myelin-associated glycoprotein (MAG): past, present and beyond. J. Neurochem., 100, 1431-1448 (2007).
5. Nakaya N, Sultana A, Lee HS, Tomarev SI. Olfactomedin 1 interacts with the Nogo A receptor complex to regulate axon growth. J. Biol. Chem., 287, 37171-37184 (2012).
6. Prinjha R, Moore SE, Vinson M, Blake S, Morrow R, Christie G, Michalovich D, Simmons DL, Walsh FS. Inhibitor of neurite outgrowth in humans. Nature, 403, 383-384 (2000).
7. Mukhopadhyay G, Doherty P, Walsh FS, Crocker PR, Filbin MT. A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron, 13, 757-767 (1994).
8. McKerracher L, David S, Jackson DL, Kottis V, Dunn RJ, Braun PE. Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron, 13, 805-811 (1994).
9. Kottis V, Thibault P, Mikol D, Xiao ZC, Zhang R, Dergham P, Braun PE. Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth. J. Neurochem., 82, 1566-1569 (2002).
10. Wong ST, Henley JR, Kanning KC, Huang KH, Bothwell M, Poo MM. A p75 (NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat. Neurosci., 5, 1302-1308 (2002).
11. Buchli AD, Schwab ME. Inhibition of Nogo: a key strategy to increase regeneration, plasticity and functional recovery of the lesioned central nervous system. Ann. Med., 37, 556-567 (2005).
12. Harel NY, Strittmatter SM. Can regenerating axons recapitulate developmental guidance during recovery from spinal cord injury? Nat. Rev. Neurosci., 7, 603-616 (2006).
13. GrandPré T, Li S, Strittmatter SM. Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature, 417, 547-551 (2002).
14. Mi S, Lee X, Shao Z, Thill G, Ji B, Relton J, Levesque M, Allaire N, Perrin S, Sands B, Crowell T, Cate RL, McCoy JM, Pepinsky RB. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat. Neurosci., 7, 221-228 (2004).
15. Seymour AB, Andrews EM, Tsai SY, Markus TM, Bollnow MR, Brenneman MM, O'Brien TE, Castro AJ, Schwab ME, Kartje GL. Delayed treatment with monoclonal antibody IN-1 1 week after stroke results in recovery of function and corticorubral plasticity in adult rats. J. Cereb. Blood Flow Metab., 25, 1366-1375 (2005).
16. Tsai SY, Markus TM, Andrews EM, Cheatwood JL, Emerick AJ, Mir AK, Schwab ME, Kartje GL. Intrathecal treatment with anti-Nogo-A antibody improves functional recovery in adult rats after stroke. Exp. Brain Res., 182, 261-266 (2007).
17. Weinmann O, Schnell L, Ghosh A, Montani L, Wiessner C, Wannier T, Rouiller E, Mir A, Schwab ME. Intrathecally infused antibodies against Nogo-A penetrate the CNS and downregulate the endogenous neurite growth inhibitor Nogo-A. Mol. Cell. Neurosci., 32, 161-173 (2006).
18. Simonen M, Pedersen V, Weinmann O, Schnell L, Buss A, Ledermann B, Christ F, Sansig G, van der Putten H, Schwab ME. Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron, 38, 201-211 (2003).
19. Kim JE, Li S, GrandPré T, Qiu D, Strittmatter SM. Axon regeneration in young adult mice lacking Nogo-A/B. Neuron, 38, 187-199 (2003).
20. Liebscher T, Schnell L, Schnell D, Scholl J, Schneider R, Gullo M, Fouad K, Mir A, Rausch M, Kindler D, Hamers FP, Schwab ME. Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats. Ann. Neurol., 58, 706-719 (2005).
21. Fischer D, He Z, Benowitz LI. Counteracting the Nogo receptor enhances optic nerve regeneration if retinal ganglion cells are in an active growth state. J. Neurosci., 24, 1646-1651 (2004).
22. Mi S, Lee X, Shao Z, Thill G, Ji B, Relton J, Levesque M, Allaire N, Perrin S, Sands B, Crowell T, Cate RL, McCoy JM, Pepinsky RB. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat. Neurosci., 7, 221-228 (2004).
23. Park JB, Yiu G, Kaneko S, Wang J, Chang J, He XL, Garcia KC, He Z. A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors. Neuron, 45, 345-351 (2005).
24. Parkhurst CN, Zampieri N, Chao MV. Nuclear localization of the p75 neurotrophin receptor intracellular domain. J. Biol. Chem., 285, 5361-5368 (2010).
25. Harrington AW, Leiner B, Blechschmitt C, Arevalo JC, Lee R, Mörl K, Meyer M, Hempstead BL, Yoon SO, Giehl KM. Secreted proNGF is a pathophysiological death-inducing ligand after adult CNS injury. Proc. Natl. Acad. Sci. U.S.A., 101, 6226-6230 (2004).
26. Zhang Z, Xu X, Zhang Y, Zhou J, Yu Z, He C. LINGO-1 interacts with WNK1 to regulate Nogo-induced inhibition of neurite extension. J. Biol. Chem., 284, 15717-15728 (2009).
27. Ahmed Z, Dent RG, Suggate EL, Barrett LB, Seabright RJ, Berry M, Logan A. Disinhibition of neurotrophin induced dorsal root ganglion cell neutite outgrowth on CNS myelin by RNA-mediated knockdown of NgR, p75NTR and Rho-A. Mol. Cell. Neurosci., 28, 509-523 (2005).
28. Zhong SQ, Sun LJ, Yan YZ, Sun YQ, Zhong YY. Effect of Xuesaitong soft capsule on hemorrheology and in auxiliarily treating patients with acute cerebral infarction. Chin. J. Integr. Med., 11, 128-131 (2005).
29. Li H, Sun HH. Clinical observation of cerebral hemorrhage treated by Xuesaitong injection. Chin J TCM WM Crit Care., 11, 50-52 (2004).
30. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomyin rats. Stroke, 20, 84-91 (1989).
31. Hansen J, Bross P., A cellular viability assay to monitor drug toxicity. Methods Mol. Biol., 648, 303-311 (2010).
32. Guan YQ, Lu BX, Pan SY, Li W. Improved nerve damage degree and body mass index score for the evaluation of the lesions range of rats cerebral infarction. Chin. J. Nerv. Ment. Dis., 35, 256-258 (2009).
33. Sommer C. Histology and infarct volume determination. Rodent Models of Stroke. (Dirnagl U ed.) Vol. 47, Springer, New York, Dordrecht-Heidelberg- London, Humana Press, pp. 13-26 (2010).